Feedback Medical appoints Dr Tom Oakley as CEO
Feedback Medical appoints radiologist and NHS England Clinical Entrepreneur Fellow
Cambridge, UK, 14 February 2019 - Feedback plc (AIM: FDBK, "Feedback", or the "Company"), the specialist medical imaging technology company, announces that its operating subsidiary, Feedback Medical Ltd, has appointed Dr Tom Oakley as its Chief Executive Officer.
A qualified clinical radiologist, Dr Oakley has significant experience of successfully launching healthcare products and helping small companies to realise and grow their market potential. This includes serving as Director of NHS services at Synergix Health, where he led the launch of telemedicine services to 40,000 patients. He also founded Innovation Doctor Ltd, a vehicle to explore the digital healthcare space, through which he has supported a number of digital start-ups and SMEs. As Medical Director of 3D LifePrints, a medical 3D printing company, he helped expand their services into 20 NHS trusts whilst also securing growth capital for the business.
Dr Oakley also has significant clinical and academic experience, having been an Academic Doctor in Oxford and an Editorial Board Member of the European Medical Journal publication, Innovation. Since 2016, he has been an NHS England Clinical Entrepreneur Fellow, a role awarded to clinicians with a track record of entrepreneurial activity, in order to help them innovate within the NHS by building networks with key healthcare decision makers.
Dr Oakley received his Bachelor of Medicine with distinction from the University of Southampton, where he also intercalated with a BSc in Biomedical Sciences. He will report directly to the board of Feedback plc. Dr Alastair Riddell will continue in his role as Executive Chairman of Feedback plc.
Tom Oakley, CEO of Feedback Medical, said:
"I am joining Feedback Medical at a key time for the company. It has great potential in a market poised for strong growth, with its innovative TexRAD® and Cadran products. I am keen to help the company consolidate its market position, identify growth areas and capture the emerging market segment within digital imaging."
Alastair Riddell, Executive Chairman of Feedback plc, said:
"Tom's proven track record in leading and developing innovative medical products, and his deep understanding of the NHS will be essential in driving growth for both TexRAD® and Cadran. His combination of clinical knowledge and understanding of market access will be valuable as Feedback Medical grows towards its potential as a leader within the digital imaging sector."
- ENDS -
Alastair Riddell, Executive Chairman
Lindsay Melvin, CFO
+44 (0)1954 718072
Rozi Morris / Deborah Bell / Phillip Marriage
+44 (0)20 7457 2020
About Feedback plc
Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer. Feedback Medical works with customers globally from headquarters in the internationally renowned scientific hub of Cambridge, UK. Its proprietary technologies are TexRAD®, the quantitative texture analysis tool and Cadran, a picture archiving communication system (PACS).
For more information, see www.fbkmed.com/plc-landing-page
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Quick facts: Feedback PLC
Market Cap: £5.39 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE